Skip to main content

Together we are beating cancer

Donate now

Showing 12 out of 18 results
Cancer Research UK logo

SOUTHAMPTON today joins a unique chain of Cancer Research UK Centres that are being launched across the UK SOUTHAMPTON today joins a unique chain of Cancer Research UK Centres that are being launched across the UK

by Cancer Research UK | News | 29 April 2009

29 April 2009

Cancer Research UK logo

Taking aspirin in your 40s could cut the risk of cancer developing later in life, according to research published in the Lancet Oncology today. Taking aspirin in your 40s could cut the risk of cancer developing later in life, according to research published in the Lancet Oncology today.

by Cancer Research UK | News | 29 April 2009

29 April 2009

Gum.

This week, newspapers claimed that nicotine could actually cause mouth cancer. But while the results are interesting, this conclusion is premature. This week, newspapers claimed that nicotine could actually cause mouth cancer. But while the results are interesting, this conclusion is premature.

by Ed Yong | Analysis | 24 April 2009

24 April 2009

  • Science & Technology
  • Health & Medicine

CHEKing genes for breast cancer clues

We look at our research into a family’s genes, which revealed a gene fault that may be responsible for a significant minority of inherited breast cancers. We look at our research into a family’s genes, which revealed a gene fault that may be responsible for a significant minority of inherited breast cancers.

by Oliver Childs | Analysis | 23 April 2009

23 April 2009

This entry is part 1 of 30 in the series Our milestones
Cancer Research UK logo

Scientists have developed a potent group of potential drug candidates to treat skin cancer, according to a study in the Journal of Medicinal Chemistry today (Thursday). Scientists have developed a potent group of potential drug candidates to treat skin cancer, according to a study in the Journal of Medicinal Chemistry today (Thursday).

by Cancer Research UK | News | 23 April 2009

23 April 2009

Cancer Research UK logo

CANCER RESEARCH UK-funded scientists have discovered that linking a molecule which initiates antibody production, to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood*, could potentially be used to selectively destroy tumour cells while ignoring healthy cells. CANCER RESEARCH UK-funded scientists have discovered that linking a molecule which initiates antibody production, to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood*, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.

by Cancer Research UK | News | 23 April 2009

23 April 2009

Cancer Research UK logo

The number of women dying from breast cancer has fallen to less than 12,000 for the first time in almost 40 years, Cancer Research UK reveals today. The number of women dying from breast cancer has fallen to less than 12,000 for the first time in almost 40 years, Cancer Research UK reveals today.

by Cancer Research UK | News | 22 April 2009

22 April 2009

Cancer Research UK logo

The 'stiletto' shoe was on the other foot in London today as a group of men joined Jade Goody's close friend Kevin Adams and actor Christopher Biggins to pay a light-hearted but touching tribute to the inspirational women in their lives, by strapping on a pair of high heels for a walk of empathy in support of Cancer Research UK's women-only Race for Life 2009 series. The 'stiletto' shoe was on the other foot in London today as a group of men joined Jade Goody's close friend Kevin Adams and actor Christopher Biggins to pay a light-hearted but touching tribute to the inspirational women in their lives, by strapping on a pair of high heels for a walk of empathy in support of Cancer Research UK's women-only Race for Life 2009 series.

by Cancer Research UK | News | 20 April 2009

20 April 2009

Cancer Research UK logo

London, April 2009 - Scientists at Cancer Research Technology Ltd (CRT) will present exciting new findings showing that a potent and selective inhibitor of protein kinase D called CRT0066101, inhibits the growth of pancreatic tumours. London, April 2009 - Scientists at Cancer Research Technology Ltd (CRT) will present exciting new findings showing that a potent and selective inhibitor of protein kinase D called CRT0066101, inhibits the growth of pancreatic tumours.

by Cancer Research Technology (CRT) | News | 19 April 2009

19 April 2009